Diabetic Peripheral Neuropathy Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Diabetic Peripheral Neuropathy Market is segmented By Treatment (Pain Management Drugs, Gene Therapies), By Disease (Type 2 Diabetic Peripheral Neuropathy, Type 1 Diabetic Peripheral Neuropathy), By Therapy (Antidepressants, Anticonvulsants), By Patient Population (Adult Patients, Geriatric Patients), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.

Diabetic Peripheral Neuropathy Market is segmented By Treatment (Pain Management Drugs, Gene Therapies), By Disease (Type 2 Diabetic Peripheral Neurop....

Diabetic Peripheral Neuropathy Market Size

Market Size in USD

CAGR9.7%

Study Period	2024 - 2031
Base Year of Estimation	2023
CAGR	9.7%
Market Concentration	High
Major Players	Helixmith, Aptinyx, WinSanTor, Inc., Regenacy Pharmaceuticals, Grünenthal GmbH

*Disclaimer: Major players are listed in no particular order.

*Source: Coherent Market Insights

Want to purchase customized report?
please let us know !

Diabetic Peripheral Neuropathy Market Analysis

The diabetic peripheral neuropathy market is estimated to be valued at USD 4.64 Bn in 2024 and is expected to reach USD 8.89 Bn by 2031, growing at a compound annual growth rate (CAGR) of 9.7% from 2024 to 2031. The market is primarily driven by the rising global prevalence of diabetes and growing geriatric population worldwide who are at a higher risk of developing diabetic peripheral neuropathy (DPN).

Diabetic Peripheral Neuropathy Market Report Snapshots

Buy Now